Drugmaker Merck & Co. plans to appeal a federal court verdict that a former subsidiary caused the commonwealth of Massachusetts to overpay pharmacists for a widely used asthma medication, the company said.
Novartis Pharmaceuticals Corp. will pay $422.5 million in penalties for marketing an epilepsy medicine for unapproved uses and for paying kickbacks to doctors to prescribe it and five other drugs, federal officials announced.
Crescendo Biologics Limited has established a colony of engineered mice completely devoid of endogenous antibody polypeptides. The mice are believed to have the immunoglobulin heavy chain, kappa light chain, and lambda light chain loci all functionally silenced.
caprotec bioanalytics GmbH announced the commercial launch of three new caproKits, enabling the discovery, identification and characterization of proteins for applications in functional proteomics and drug development.
Covance Inc. announced the expansion of its biotechnology offerings into North America with the opening of a biotechnology services facility on its Greenfield campus in Indiana.
DaVita Clinical Research has announced the launch of its clinical central lab facility. The over-47,000 square foot facility allows technicians to perform approximately 114,000 tests on 60,000 samples daily.
Synosia Therapeutics announced the first clinical study results showing that SYN-118 provides clinically meaningful benefits to Parkinson’s patients, has a good safety profile and is well tolerated.
In recent human trials for a promising new class of drug designed to target the hepatitis C virus without shutting down the immune system, some of the HCV strains being treated exhibited signs of drug resistance.
Researchers at the Indiana University Melvin and Bren Simon Cancer Center have published the first report using imaging to show that changes in brain tissue can occur in breast cancer patients undergoing chemotherapy.
Phase 3 safety and efficacy data comparing tapentadol extended release (ER) tablets, an investigational pain medication, to placebo in patients with moderate to severe chronic low back pain have been published online.
A federal judge in Delaware has ruled against French drug maker Sanofi-Aventis SA in a patent dispute involving its cancer drug Taxotere.
In spring 2009, a group of contract workers, going mostly to gas station convenience stores, bought up thousands of bottles of Motrin that had been determined to be defective but not dangerous. The workers had been hired for Johnson and Johnson, which wanted to remove the pills from the market without issuing a public recall.
Seniors with high drug costs will soon have more options to help them cope with Medicare's prescription coverage gap. Reversing a steady decline, the number of prescription plans covering at least some brand-name drugs in the "doughnut hole" will triple next year.
Malawi's vice president says her AIDS-ravaged southern African country will adopt the latest U.N. health guidelines that call for putting HIV-positive people on drugs sooner.
The chief executive of Johnson and Johnson will tell Congress his company "let the public down" with a string of quality problems that have resulted in millions of recalled medicines.